Literature DB >> 12675863

Aortic pulse wave velocity index and mortality in end-stage renal disease.

Jacques Blacher1, Michel E Safar, Alain P Guerin, Bruno Pannier, Sylvain J Marchais, Gérard M London.   

Abstract

BACKGROUND: Aortic pulse wave velocity (PWV) is a strong independent predictor of overall and cardiovascular mortality in patients with end-stage renal disease (ESRD). Nevertheless, because age, blood pressure, heart rate, and gender are strong determinants of both arterial stiffness and mortality, the individual relevance of PWV measurements remains controversial.
METHODS: A cohort of 242 patients with ESRD undergoing hemodialysis was studied for a mean (+/- SD) duration of 78 +/- 46 months. At entry, together with standard clinical and biochemical analyses, PWV was measured using Doppler ultrasonography. On the basis of a nomogram established on 469 nonuremic subjects, a theoretical value of PWV was determined in ESRD patients according to their age, blood pressure, gender, and heart period. The PWV index (measured PWV - theoretical PWV) was then calculated for each individual ESRD patient.
RESULTS: Based on Cox analysis, the PWV index, but neither pulse pressure nor cardiac mass, was a strong and independent predictor of both cardiovascular and overall mortality, together with age and time on dialysis before inclusion. Patients with positive (versus negative) PWV index had a twofold adjusted risk of mortality during the follow-up. Per each 1 meter/second PWV index increment, we observed a 34% (crude) and a 14% (adjusted) increase in both cardiovascular and overall mortality (P < 0.02 for all).
CONCLUSION: In ESRD patients, the calculation of a PWV index provides information about cardiovascular and overall mortality risk with high predictive power, showing that PWV measurements provide discriminatory prognostic power over and above conventional cardiovascular risk factors.

Entities:  

Mesh:

Year:  2003        PMID: 12675863     DOI: 10.1046/j.1523-1755.2003.00932.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  125 in total

1.  Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.

Authors:  Min Ji Shin; Sang Heon Song; Ihm Soo Kwak; Soo Bong Lee; Dong Won Lee; Eun Young Seong; Il Young Kim; Harin Rhee; Naria Lee
Journal:  Clin Exp Nephrol       Date:  2012-01-26       Impact factor: 2.801

Review 2.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

3.  Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients.

Authors:  Tuomo Nieminen; Hannu Uusitalo; Väinö Turjanmaa; Gunilla Bjärnhall; Hans Hedenström; Jukka Mäenpää; Auli Ropo; Pekka Heikkilä; Mika Kähönen
Journal:  Eur J Clin Pharmacol       Date:  2005-05-24       Impact factor: 2.953

4.  Age related changes of human aortic distensibility: evaluation with ECG-gated CT.

Authors:  Marika Ganten; Ute Krautter; Waldemar Hosch; Jochen Hansmann; Hendrik von Tengg-Kobligk; Stefan Delorme; Hans-Ulrich Kauczor; Günter W Kauffmann; Michael Bock
Journal:  Eur Radiol       Date:  2006-05-24       Impact factor: 5.315

5.  Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients.

Authors:  J K Inrig; E Z Oddone; V Hasselblad; Barbara Gillespie; U D Patel; D Reddan; R Toto; J Himmelfarb; J F Winchester; J Stivelman; R M Lindsay; L A Szczech
Journal:  Kidney Int       Date:  2007-01-10       Impact factor: 10.612

6.  Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease.

Authors:  Ashwini Pai; Elizabeth M Leaf; Mohga El-Abbadi; Cecilia M Giachelli
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 7.  Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine.

Authors:  Ali R Khoshdel; Shane L Carney; Balakrishnan R Nair; Alastair Gillies
Journal:  Clin Med Res       Date:  2007-03

Review 8.  Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk.

Authors:  Todd J Anderson
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

9.  Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.

Authors:  Michael E Seifert; Lisa de Las Fuentes; Charles Ginsberg; Marcos Rothstein; Dennis J Dietzen; Steven C Cheng; Will Ross; David Windus; Victor G Dávila-Román; Keith A Hruska
Journal:  Am J Nephrol       Date:  2014-05-06       Impact factor: 3.754

10.  Design of a Continuous Blood Pressure Measurement System Based on Pulse Wave and ECG Signals.

Authors:  Jian-Qiang Li; Rui Li; Zhuang-Zhuang Chen; Gen-Qiang Deng; Huihui Wang; Constandinos X Mavromoustakis; Houbing Song; Zhong Ming
Journal:  IEEE J Transl Eng Health Med       Date:  2018-01-18       Impact factor: 3.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.